Gaucher Disease Clinical Trials

A listing of Gaucher Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 30 clinical trials
Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease

The objective of this study is to evaluate oxidative stress and/or inflammation in patients with Gaucher disease type I using a series of biomarkers and correlate with measurements of currently

antioxidants
  • 8 views
  • 27 Jul, 2022
  • 1 location
Survey Study for Velaglucerase Alfa (VPRIV) in Japan

The objective of this post-marketing survey study is to collect data to determine the safety and efficacy of velaglucerase alfa (VPRIV) in participants with Gaucher disease who are new to

vpriv
velaglucerase alfa
  • 74 views
  • 12 Feb, 2022
  • 31 locations
Post Marketing Surveillance (PMS) Study for Velaglucerase Alfa (VPRIV) in India

record genetic mutation data from participants with Gaucher disease.

vpriv
velaglucerase alfa
  • 0 views
  • 21 Aug, 2021
  • 2 locations
A Study of Velaglucerase Alfa (VPRIV) Given as Standard Patient Care in Young Children With Gaucher Disease (PEDS)

The main aim of this study is to learn if velaglucerase alfa (VPRIV) improves growth and symptoms in participants under 5 years old with Gaucher disease. Symptoms will be checked with blood

vpriv
velaglucerase alfa
  • 0 views
  • 24 Jul, 2022
  • 1 location
The GBA Multimodal Study in Parkinson's Disease

This study plans to analyze the molecular and clinical mechanisms of the relationship between the GBA mutations and Parkinson's disease. This will be assessed through the use of advanced neuroimaging techniques called PET (positron emission tomography) to study the accumulation of the tau protein and the dysfunction of acetylcholine and …

gba gene
acetylcholine
parkinson's disease
positron emission tomography
dopamine
  • 0 views
  • 25 Jan, 2022
  • 3 locations
World Data on Ambroxol for Patients With GD and GBA Related PD

and efficacy of ambroxol for patients with Gaucher disease (GD).

alglucerase
type 1 gaucher disease
  • 2 views
  • 05 Jun, 2022
  • 2 locations
A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen (OPPUS)

Primary Objective: To assess prevalence of Gaucher disease (GD) diagnosed in pediatric patients presenting with unexplained splenomegaly (SMG) after exclusion of first intention-diagnoses

  • 0 views
  • 24 Jun, 2022
  • 2 locations
A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen (OPPUS)

Primary Objective: To assess prevalence of Gaucher disease (GD) diagnosed in pediatric patients presenting with unexplained splenomegaly (SMG) after exclusion of first intention-diagnoses

  • 0 views
  • 07 Jul, 2022
  • 37 locations
Natural History of Glycosphingolipid and Glycoprotein Lysosomal Storage Disorders

treatment. Patients of any age with Tay-Sachs disease, Sandhoff disease, GM1 gangliosidosis, or type 2 Gaucher disease may be eligible for this study. Participants will be admitted to the NIH

deficiency
MRI
  • 76 views
  • 25 Jul, 2022
  • 1 location
COVID-19 and Hereditary Metabolic Diseases (COVID19-MHM)

diagnosed in a given group of IMD when the number of patients with this IMD is known (Urea Cycle Deficiency, Gaucher Disease). b. to evaluate the impact of IMD on the and severity of COVID-19 infection

  • 0 views
  • 10 Mar, 2022
  • 1 location